Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 632 * | Thu, 8/7/2014, 10:30 AM - 12:20 PM | CC-254B | |
| Biomarkers in Clinical Trials and the Regulatory Environment — Topic Contributed Papers | |||
| Biopharmaceutical Section | |||
| Organizer(s): Lixia Pei, Janssen | |||
| Chair(s): Thian Kheoh, Janssen | |||
| 10:35 AM | Biomarker-Based Clinical Trials: an Overview — Daniel Sargent, Mayo Clinic ; William Barry, Dana-Farber Cancer Institute | ||
| 10:55 AM | Biomarker Driven Population Enrichment for Adaptive Oncology Trials — Cyrus Mehta, Cytel | ||
| 11:15 AM | Immunobridging Formula for Predicting Vaccine Efficacy, Accounting for Baseline Covariates, Post-Baseline Biomarker Surrogate Endpoints, and Geno/Serotypes of Circulating Pathogens — Peter Gilbert, Fred Hutchinson Cancer Research Center | ||
| 11:35 AM | Implementation of NGS Genomics Data in Oncology Clinical Trials: Analytical Issues and Lessons Learned — Ray Liu, Takeda ; Feng Gao, Takeda ; Jacob Zhang, Takeda | ||
| 11:55 AM | Discussant: Rajeshwari Sridhara, FDA | ||
| 12:15 PM | Floor Discussion | ||
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.